Melanoma Bridge 2023


 

Expectations, Concerns, and The Unknown: A SITC Perspective on Survivorship Following Immune Checkpoint Inhibitor Therapy for Patients With Cancer

55 views
December 28, 2023
Comments 0
Login to view comments. Click here to Login